Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |